M. Singh, U. C. Banerjee / Tetrahedron: Asymmetry 18 (2007) 2079–2085
2085
The optimum temperature was determined by incubating
the lipase with the substrate at different temperatures in
the range 20–60 ꢀC. To find out the effect of substrate con-
centration, varying amounts of rac-CDPP (1–10 mM) were
subjected to transesterification by P. aeruginosa. Finally, in
order to optimize the concentration of the acyl donor,
reactions were carried out by varying the concentrations
of vinyl butyrate (100–200 mM) and keeping the other
parameters constant. The samples were taken and analyzed
for transesterification efficiency and enantioselectivity.
a Shimadzu 10AVP Instrument equipped with a UV detec-
tor using a Chiracel ODH column (0.46 mm diam.,
250 mm long, 5 lm, Chiralcel). The mobile phase was hex-
ane–isopropyl alcohol at 95:05 (v/v) with a flow rate of
0.5 ml/min and detected at 220 nm. The retention times
of (S)- and (R)-1-chloro-3-(3,4-difluorophenoxy)-2-propa-
nol were 23 and 24.7 min, respectively, and the retention
time for the (S)-ester was 12.2 min in the Chiracel ODH
column. The ee was defined as the ratio of [R] ꢁ [S]/
[R] + [S] · 100%, where [R] and [S] are the concentrations
1
of the (R)- and (S)-enantiomers, respectively. H and 13C
4.8. Preparative-scale transesterification
NMR spectra were recorded on a Bruker Advance DPX
300 NMR spectrometer and optical rotations were mea-
sured on a Rudolph polarimeter (Rudolph Research Auto-
pol IV).
In order to scale-up the transesterification of rac-CDPP,
when the reaction was carried out at a preparative scale
with 3 g rac-CDPP, (S)-1-chloro-3-(3,4-difluorophenoxy)-
2-butanoate was obtained at a conversion of about 42%
with an ee >99%. This suggests that the crude lipase mix-
ture of P. aeruginosa is a versatile biocatalyst, able to
transesterify (RS)-1-chloro-3-(3,4-difluorophenoxy)-2-pro-
panol with excellent enantioselectivity. Also, the results
demonstrated promising prospects for the practical appli-
cation of P. aeruginosa in the production of (R)-1-chloro-
3-(3,4-difluorophenoxy)-2-propanol, a key intermediate in
the synthesis of anti-ischemic drug (S)-Lubeluzole.
Acknowledgments
We are grateful to Dr. A. K. Chakraborti for the helpful
discussion and for providing full access to his laboratory.
M.S. gratefully acknowledges the Department of Science
and Technology (DST), India, for providing fellowship.
This is NIPER Communication No. 402.
22
For the (S)-ester, ½aꢂD ¼ þ18:9 (c 1, CHCl3).Yellowish li-
quid, IR (Neat): 2965, 2934, 1743, 1609, 1518, 1462,
1435, 1327, 1262, 1216, 1204, 1162, 1101, 1043, 983, 963,
References
851, 786, 704 cmꢁ1
.
1H NMR (300 MHz, CDCl3):
d = 7.02–7.11 (m, 1H), 6.71–6.77 (m, 1H), 6.60–6.63 (m,
1H), 5.31–5.34 (m, 1H), 4.13 (s, 1H), 4.11 (s, 1H), 3.81–
3.85 (m, 1H), 3.73–3.78 (m, 1H), 2.33–2.38 (t,
J = 7.18 Hz, 2H), 1.62–1.73 (m, J = 7.16 Hz, 2H), 0.83–
0.87 (t, J = 7.07 Hz, 3H). 13C NMR (75 MHz, CDCl3):
d = 171.78, 153.53, 150.99, 146.08, 116.42, 108.86, 103.61,
69.50, 65.81, 41.3, 34.99, 17.37, 13.09. MS (MALDI-
TOF) m/z = 315.50 (M+), 242 (100).
1. Patel, R. N. Stereoselective Biocatalysis; Dekker: New York,
2000, pp 839–866.
2. Drauz, K.; Waldmann, H. Enzyme Catalysis in Organic
Synthesis, 2nd ed; Wiley-VCH, 2002; Vols. 1–3.
3. Pollard, D. J.; Woodley, J. M. Trends Biotechnol. 2007, 25,
66–73.
4. Bornscheuer, U. T.; Kazlauskas, R. J. Hydrolases in Organic
Synthesis: Regio- and Stereoselective Transformations; Wiley-
VCH: Weinheim, Germany, 1999.
5. Faber, K. Biotransformations in Organic Chemistry, 4th ed.;
Springer: Berlin, Heidelberg, New York, 2000.
6. Asano, Y. J. Biotechnol. 2002, 94, 65–72.
7. Lodder, J.; Grotta, J. Stroke 1998, 29, 1067.
8. Liu, H. L.; Hoff, B. H.; Berg, T. C.; Anthonsen, T. Chirality
2001, 13, 135–139.
9. Bruno, C.; Carocci, A.; Catalano, A.; Cavalluzzi, M. M.;
Corbo, F.; Franchini, C.; Lentini, G.; Tortorella, V. Chirality
2006, 18, 227–231.
10. Sharma, R.; Singh, S.; Roy, A.; Chawla, H. P. S.; Kaul, C. L.;
Banerjee, U. C. Indian Patent 1358/DEL/2003, 2003.
11. Singh, S.; Banerjee, U. C. J. Mol. Catal. B: Enzym. 2005, 36,
30–35.
22
For the (R)-alcohol, ½aꢂD ¼ ꢁ1:9 (c 1.14, CHCl3). IR
(KBr): 3399, 2937, 2873, 1611, 1517, 1464, 1437, 1260,
1211, 1162, 1116, 1037, 957, 840, 783 cmꢁ1 1H NMR
.
(300 MHz, CDCl3): d = 7.01–7.11 (m, 1H), 6.70–6.77 (m,
1H), 6.59–6.63 (m, 1H), 4.17–4.24 (m, 1H), 4.01–4.03 (m,
2H), 3.68–3.79 (m, 1H), 3.13 (br s, 1H). 13C NMR
(75 MHz, CDCl3): d = 155.1, 155.0, 152.6, 152.5, 149.4,
149.2, 147.5, 147.4, 144.4, 144.2, 117.9, 117.7, 110.4,
105.0, 104.7. The above spectroscopic data were in agree-
ment with the literature.8
4.9. Effect of various biocatalysts
12. Goswami, A.; Goswami, J. Tetrahedron Lett. 2005, 46, 4411–
4413.
13. Yadav, G. D.; Trivedi, A. H. Tetrahedron Lett. 2003, 32, 783–
789.
14. Rizzi, M.; Stylos, P.; Riek, A.; Reuss, M. Enzyme Microb.
Technol. 1992, 14, 709–714.
15. Faber, K.; Riva, S. Synthesis 1992, 895–910.
16. Hiratake, J.; Yamamoto, K.; Yamamoto, Y.; Oda, J.
Tetrahedron Lett. 1989, 30, 1555–1556.
17. Singh, M.; Khokale, P.; Rudrawar, S.; Banerjee, U. C.;
Chakraborti, A. K. Indian Patent 2570/DEL/2006, 2006.
18. Winkler, U. K.; Stuckmann, M. J. Bacteriol. 1979, 138, 663–
670.
Purified lipases from different sources (C. rugosa and Por-
cine pancreatic) were evaluated for the transesterification
of rac-CDPP with vinyl butyrate at 30 ꢀC. The results for
conversion and enantioselectivity were compared with the
crude lipases from P. aeruginosa.
4.10. Analytical methods
Conversion and the enantiomeric excess of the transesteri-
fication reaction were monitored by HPLC performed on